Literature DB >> 1361110

Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.

C B Nemeroff1, B Levant, B Myers, G Bissette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1361110     DOI： 10.1111/j.1749-6632.1992.tb27346.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.

Authors:  R Fernández; R Sabater; J A Sáez; R Montes; F Alba; J M Ferrer
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation.

Authors:  S Y Choi; H D Chae; T J Park; H Ha; K T Kim
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.

Authors:  J M Radke; M J Owens; J C Ritchie; C B Nemeroff
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.

Authors:  P D Shilling; G Melendez; K Priebe; E Richelson; D Feifel
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

6.  Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.

Authors:  Siobhan Briody; Mona Boules; Alfredo Oliveros; Irfan Fauq; Elliott Richelson
Journal:  Behav Brain Res       Date:  2009-10-02       Impact factor: 3.332

7.  A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties.

Authors:  Hee-Kyoung Lee; Liuyin Zhang; Misty D Smith; Aleksandra Walewska; Nadeem A Vellore; Riccardo Baron; J Michael McIntosh; H Steve White; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

Review 8.  Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.

Authors:  Mona M Boules; Paul Fredrickson; Amber M Muehlmann; Elliott Richelson
Journal:  Behav Sci (Basel)       Date:  2014-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.